Mirabegron and/or carvedilol activate colonic PPAR-γ but inhibit the GSK3-β/NF-κB/TNF-α axis and lipid peroxidation in rats with IAA-induced ulcerative colitis. The gene discussed is NFKB1; the disease is ulcerative colitis.